03/11/2023 - General information
The award was given to a study presented by Dr. Joan Jiménez Balado from the Neurovascular Research Group at the Hospital del Mar Research Institute. The study titled "DNA-Methylation and Stroke Prognosis: an Epigenome-wide Association Study," presented by Dr. Joan Jiménez Balado, received the award for Best Communication at the 29th edition of the Stroke Genetics Workshop organized by the International Stroke Genetics Consortium in Boston, United States, from October 12 to 14.
Més informació "Award for Best Communication at the Stroke Genetics Workshop"
02/11/2023 - General information
On Monday, October 30th, the Anti-Doping Laboratory of Catalonia received a visit from Catalan sports authorities: Mrs. Anna Caula Paretas, Secretary General of Sports and Physical Activity; Mr. Aleix Villatoro Oliver, Director of the Catalan Sports Council (CCE); and Dr. Daniel Brotons Cuixart, Head of the Sports and Health Unit of the CCE. The Laboratory is one of the 30 laboratories accredited worldwide by the World Anti-Doping Agency (WADA) to analyze samples from athletes. The visit showcased its complexity, as it has to meet stringent technical and quality requirements imposed by WADA to maintain accreditation.
Més informació "Visits by Catalan Sports Authorities to the Anti-Doping Laboratory of Catalonia"
A study involving the Hospital del Mar Research Institute, the Vall d'Hebron Institut d'Oncologia, IDIBELL, and the Institut Català d'Oncologia suggests that combining chemotherapy with drugs that can inhibit two cell signaling pathways involved in tumor progression may aid in treatment. The research has analyzed the interaction of the protein IKKα with these pathways, known for their ability to promote the proliferation of tumor cells. This combination has the advantage of reducing treatment toxicity. The study opens the door to new approaches for tumors with the presence of this protein. It is published in the EMBO Journal.
Més informació "A possible new combination of treatments to combat cancer"
24/10/2023 - Events
As some of you already know, this year the IMIM (now the Hospital del Mar Research Institute) is 75 years old. To commemorate this anniversary, different activities have been programmed, such as the exhibition on the history of the institution that could be visited in the Paseo Marítimo this summer. Continuing with the celebrations, the Scientific Retreat 2023 will take place on 8 November in the PRBB Auditorium. In this edition, in addition to the usual scientific presentations, the event will include the participation of the former directors of the institution, in a round table moderated by Jessica Mouzo, journalist specialised in health and science of the newspaper "El País".
17/10/2023 - Institutional news
The 2023 call of the new CaixaImpulse Innovation program will award 3.3 million euros to 29 biomedical research projects, 15 of which come from Catalan research centers. The aim is to contribute to bringing research results to society and the market, fostering the creation of new products, services and companies related to life sciences and health. The two selected projects focus on developing a new sampling system to facilitate early diagnosis of pancreatic cancer and a new immunotherapy treatment for breast cancer. This initiative offers the selected entrepreneurial scientists financial support and accompaniment through individualized mentoring and training, in collaboration with Caixa Capital Risc and in partnership with the Fundação para a Ciência e a Tecnologia (FCT), of the Portuguese Ministry of Science, Technology and Higher Education, which is funding two projects in this call.
11/10/2023 - Institutional news
The prizes were awarded at the SEOM congress held in Barcelona at the end of September. The doctoral thesis of Dr. Pedro Rocha, assistant doctor at the Oncology Department of the Hospital del Mar and researcher at the Hospital del Mar Research Institute, has received one of the five grants awarded by the Spanish Society of Medical Oncology (SEOM) to doctoral theses by young researchers. The award ceremony took place on 22 September during the congress of the organisation.
05/10/2023 - Press release
A study led by researchers at the Hospital del Mar Research Institute identifies that the deterioration of the blood-brain barrier, which regulates exchanges between the blood and the brain, can be used to identify which of these patients will have a more rapid progression. In the patients analysed, the risk of accelerated disease progression increases by 8% for every 10% increase in the level of albumin in cerebrospinal fluid and blood (a biomarker of damage to the blood-brain barrier). The results indicate that restoring the blood-brain barrier's ability to protect the brain could help slow the worsening of patients. This marker will allow a more accurate assessment of the prognosis of patients with cognitive impairment caused by Alzheimer's and other dementias. The work is published in the journal Alzheimer's&Dementia.
04/10/2023 - Institutional news
On October 7 from 10:00 to 14:30 h comes a new edition of the Open Day of the Barcelona Biomedical Research Park (PRBB) in which researchers will explain firsthand what they do, how they do it and where they do it. The different research centers that are part of the PRBB will offer a wide range of free activities for the whole family. On Saturday morning, children over 12 years old will be able to learn about science from its protagonists with guided tours. From 10:00 to 13:30h we have prepared several routes that will simultaneously tour the building and visit different laboratories. In the case of the Hospital del Mar Research Institute you will be able to visit the Bioinformatics Unit, the laboratoris of stem cell and cancer, immune redirection, applied metabolomics and evolutionary genomics where each of them will explain what their work consists of and the research they are currently doing.
Més informació "OPEN PRBB 2023: On Saturday, October 7, we open the doors again to everyone"
29/09/2023 - Institutional news
We are pleased to announce the official launch of the MARMetabolomics service, a pioneering initiative in the field of metabolomics at the Hospital del Mar Research Institute. MARMetabolomics is an advanced platform developed by the Applied Metabolomics Research Group (LIMA), which has extensive experience in the development of analytical methods for the determination of metabolites (small molecules involved in metabolic reactions that take place in biological systems) in both non-invasive (urine, breast milk, hair or cultures) and invasive (CSF, blood or tissues) matrices and their application in the field of health. The platform is a member of the European Infrastructure for Translational Medicine (EATRIS), the Spanish Metabolomics Network and the multidisciplinary center TECNIO, BAPP.
Més informació "Inauguration of the MARMetabolomics Service at Hospital del Mar Research Institute"
27/09/2023 - Press release
Research conducted in a mouse model identifies the neurobiological mechanism responsible for alterations in the memory of young individuals exposed to alcohol during pregnancy and lactation. This study proposes a therapy that can reverse the deficit, paving the way for treating a disorder that is underdiagnosed in humans.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
